QR код

Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C

Background Lymphocytic choriomeningitis virus (LCMV) belongs to the Arenavirus family known for inducing strong cytotoxic T-cell responses in both mice and humans. LCMV has been engineered for the development of cancer immunotherapies, currently undergoing evaluation in phase I/II clinical trials. I...

Повний опис

Збережено в:
Автори: Pedro Berraondo, Ignacio Melero, Marisol Quintero, Fernando Aranda, Maite Alvarez, Henning Lauterbach, Myriam Fernandez-Sendin, Claudia Augusta Di Trani, Nuria Ardaiz, Celia Gomar, Angela Bella, Jose Gonzalez-Gomariz, Leire Arrizabalaga, Joan Salvador Russo-Cabrera, Timo Schippers, Klaus K Orlinger
Формат: Artigo
Мова:Inglês
Опубліковано: BMJ Publishing Group 2024-04-01
Серія:Journal for ImmunoTherapy of Cancer
Онлайн доступ:https://jitc.bmj.com/content/12/4/e008287.full
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси